1h Free Analyst Time
The publisher has been monitoring the point of care glucose testing market and it is poised to grow by $ 972.07 mn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. The report on the point of care glucose testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in the number of diabetes cases and rising awareness about diabetes, a growing geriatric population, and increasing unmet medical needs for the diagnosis and management of diabetes. The point of care glucose testing market analysis includes type segment and geographic landscape.
The publisher's point of care glucose testing market is segmented as below:
By Type
- Strips
- Lancets and lancing devices
- Meters
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.The report on point of care glucose testing market covers the following areas:
- Point of care glucose testing market sizing
- Point of care glucose testing market forecast
- Point of care glucose testing market industry analysis .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.uch as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global point of care glucose testing market: Abbott Laboratories, ACON Laboratories Inc., Bayer AG, Becton Dickinson and Co., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Johnson and Johnson, LifeScan IP Holdings LLC, Nipro Corp., Nova Biomedical Corp., PHC Holdings Corp., Prodigy Diabetes Care LLC, PTS Diagnostics, Sekisui Medical Co. Ltd., Siemens Healthineers AG, Trinity Biotech Plc, and Trivida Health Inc.Commenting on the report, an analyst from the publishing company said: "The latest trend gaining momentum in the market is focused on introducing low-cost test strips."
According to the report, one of the major drivers for this market is the increase in the number of diabetes cases and raising awareness about diabetes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- ACON Laboratories Inc.
- Bayer AG
- Becton Dickinson and Co.
- Danaher Corp.
- EKF Diagnostics Holdings Plc
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson
- LifeScan IP Holdings LLC
- Nipro Corp.
- Nova Biomedical Corp.
- PHC Holdings Corp.
- Prodigy Diabetes Care LLC
- PTS Diagnostics
- Sekisui Medical Co. Ltd.
- Siemens Healthineers AG
- Trinity Biotech Plc
- Trivida Health Inc.
